Schond L. Greenway - CFO at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Cfo
Issuer Symbol
AVTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Schond L. Greenway since 13 Mar 2025

Holdings reported by Schond L. Greenway for Avalo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,883 $2,017 $0.5194 10 Dec 2021 Direct

Transactions reported by Schond L. Greenway for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.